Kathryn Taylor: Publications

The Kathryn Taylor Lab
Publications

Kathryn Taylor: Publications

Share
Share

K.R. Taylor, T. Barron, A. Hui, A. Spitzer, B. Yalçin, A.E. Ivec, A.C. Geraghty, G.H. Hartmann, M. Artz, S.M. Gillespie, Y.S. Kim, S. M. Jahan, H. Zhang, K. Shamardani, M. Su, L. Ni, P.P. Du, P.J. Woo, A. Silva-Torres, H.S. Venkatesh, R. Mancusi, A. Ponnuswami, S. Mulinyawe, M.B. Keough, I. Chau, R. Aziz-Bose, I. Tirosh, M.L. Suvà and M. Monje. “Glioma synapses recruit mechanisms of adaptive plasticity”. Nature. 2023; 623(7986):366-374.

K. R. Taylor and M. Monje. “Neuron-oligodendroglial interactions in health and malignant disease”. Nature Reviews Neuroscience. 2023; 24(12):733-746.

K.R. Taylor, A. Mackay, N. Truffaux, O. Morozova, Y. Butterfield, C. Philippe, M. Vinci, D. Carvalho, C. de Torres, O. Cruz, J. Mora, D. Hargrave, M. Monje, S. Puget, S. Yip, C. Jones and J. Grill. (2014) “Recurrent activating ACVR1/ALK2 mutations in diffuse intrinsic pontine glioma”. Nature Genetics. 2014; 46(5):457-61.

D. Carvalho*, K.R. Taylor*, N.G. Olaciregui, V. Molinari, M .Clarke, A. Mackay, R. Ruddle, A. Henley, M. Vallenti, A. Hayes, A.D.H. Brandon, S.A. Eccles, F. Raynaud, A. Boudhar, M. Monje,

S. Popov, A.S. Moore, J. Mora O. Cruz, M. Vinci, P. Brennan, A.N. Bullock, A.M. Carcaboso and, C. Jones. “ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma.” Communications Biology. 2019;(2)1-10.

K. R. Taylor and M. Monje. “Invasive glioma cells: The malignant pioneers that follow the current”. Cell. 2023; 185 (16): 2846-2848.

K.R. Taylor, M. Vinci, A.N. Bullock, C. Jones. “ACVR1 Mutations in DIPG: Lessons learned from FOP”. Cancer Research. 2014; 74 (17): 4565-70.

H. Venkatesh, W. Morishita, W. Morishita, A. Geraghty, D. Silverbush, S. Gillespie, M. Artz, L. Tam, C. Espenel, A. Ponnuswami, L. Ni, P.J. Woo, K.R. Taylor, A. Agarwal, A. Regev, D. Brang, H. Vogel, S. Hervey- Jumper, D.E. Bergles, M. Suva, R. Malenka and M. Monje. “Electrical and synaptic integration of glioma into neural circuits” Nature. 2019; 573 (7775),539-545.

T. Barron, B. Yalçin, A. Mochizuki, E. Cantor, K. Shamardani, D. Tlais, A. Franson, S. Lyons, V. Mehta, S.M. Jahan, K.R. Taylor, M.B. Keough, H. Xu, M. Su, M.A. Quezada, P.J. Woo, P.G. Fisher, C.J. Campen, S. Partap C. Koschmann and M. Monje. “GABAergic neuron-to-glioma synapses in diffuse midline gliomas”. BioRxiv, Nov 9, 2022.

E. Huang-Hobbs, Y.T. Cheng, Y.T. Cheng, Y. Ko, E. Luna-Figueroa, B. Lozzi, K.R. Taylor, M. McDonald, P. He, H.C. Chen, Y. Yang, E. Maleki, Z. F. Lee, S. Murali, M.R. Williamson, D. Choi, R. Curry, J. Bayley, J. Woo, A. Jalali, M. Monje, J.L. Noebels, A. S. Harmanci, G. Rao and B. Deneen. “Remote neuronal activity drives glioma progression through SEMA4F”. Nature. 2023; 619 (7971);844-850.

B. Yalcin, M.B. Pomrenze, K. Malacon, R. Drexler, A.E. Rogers, K. Shamardani, I.J. Chau, K.R. Taylor, L. Ni, D. Contreras-Esquivel, R.C. Malenka and M. Monje. “Myelin plasticity in ventral tegmental area is required for opioid reward”. Nature, 2024; 630(8017):677-685.

M. Vinci, A. Burford, V. Molinari, K. Kessler, S. Popov, M. Clarke, K.R. Taylor, H.N. Pemberton, C.J. Lord, A. Gutteridge, T. Forshew, D. Carvalho, LV. Marshall, E.Y. Qin, W.J. Ingram, A. Moore, H.K. Ng, S. Trabelsi, D Brahim, N. Entz-Werle, S. Zacharoulis, S. Vaidya, H.C. Mandeville, L.R. Bridges, A.J. Martin, S. Al-Sarraj, C. Chandler, M. Sunol, J. Mora, C. de Torres, O. Cruz, A.M. Carcaboso, Monje M, A. Mackay and C. Jones. “Functional diversity and co- operativity of subclonal populations of paediatric glioblastoma and diffuse intrinsic pontine glioma cells”. Nature Medicine. 2018; (8):1204-1215.

A. Mackay, A. Burford, D. Carvalho, E. Izquierdo, J. Fazal-Salom, K.R. Taylor, L. Bjerke, M. Clarke, M. Vinci, M. Nandhabalan, S. Temelso, S. Popov, V. Molinari, P. Raman, A.J. Waanders, H.J. Han, S. Gupta, L. Marshall, S. Zacharoulis, S. Vaidya, H.C. Mandeville, L.R. Bridges, A.J. Martin, S. Al-Sarraj, C. Chandler, H.K. Ng, X. Li, K. Mu, S. Trabelsi, D Brahim, A.N. Kislijakov, D.M. Konovalov, A. Moore, A.M. Carcaboso, M. Sunol, C. de Torres, O. Cruz, J. Mora, L.I. Shats, J.N. Stavale, L.T. Bidnotto, R.M. Reis, N. Entz-Werle, M. Farrell, J. Cryan, D. Crimmins, J. Caird, J. Pears, m. Monje, M.A. Debily, D. Castel, J. Grill, C. Hawkins, H. Nikbakht, N. Jabado, S.J. Baker, S.M. Pfister, D.T.W. Jones, M. Fouladi, A.O. von Bueren, M. Baudis, A. Resnick and C. Jones. “Intergrated molecular meta-analysis  of  1,000 pediatric high-grade and diffuse intrinsic pontine glioma”. Cancer Cell. 2017; 32(4):520-537.

S. Nagaraja, N.A. Vitanza, P. Woo, K.R. Taylor, F. Liu, L. Zhang, M. Li, W Meng, A. Ponnuswami, W. Sun, J. Ma, E. Hulleman, T. Swigut, J. Wysocka, Y. Tang and M. Monje. “Transcriptional dependencies in diffuse intrinsic pontine glioma”. Cancer Cell. 2017; 31(5):635-652.

P. Buczkowicz, C. Hoeman, P. Rakopoulos, S. Pajovic, L. Letourneau, M. Dzamba, A. Morrison, P. Lewis, E. Bouffet, U. Bartels, J. Zuccaro, S. Agnihotri, S. Ryall, M Barszczyk, Y. Chornenkyy, M. Bourgey, G. Bourque, A. Montpetit, F. Cordero, P. Castelo-Branco, J. Magerel, U. Tabori, K.C Ho, A. Huang, K.R. Taylor, A. Mackay, A. E. Bendel, J. Nazrian, J.R. Fangusaro, M. A. Karajannis, D. Zagzag, N.K. Foreman, A. Donson, J.V. Herget, A. Smith, J. Chan, L. Lafay- Cousin, S. Dunn, J. Hukin, C. Dunham, K. Scheinemann, J. Michaud, S. Zelcer, D. Ramsay, J. Cain, C. Brennen, M.M Souweidane, C. Jones, C.D. Allis, M. Brudno, O. Becher, and C. Hawkins. “Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations”. Nature Genetics. 2014; 46(5): 451-56.

E.M. Gibson, F.C. Bennet, S.M. Gillespie, A.D. Güler, D.H. Gutmann, C.H. Halperm, S.C. Kucenas,C.A. Kushida, M. Lemieux, S. Liddelow, S.L. Macauley, Q. Li, M.A. Quinn, L.W. Roberts, N. Saligrama, K.R. Taylor, H.S. Venkatesh, B. Yalçin, J.B. Zuchero. “How Support of Early Career Reseasrchers Can Reset Science in the Post-COVID19 World”. Cell, 2020; 181 (7):1445-1449.

J. Selfe, N.C. Goddard, A. McIntyre, K.R. Taylor, J. Renshaw, S. Popov, K Thway, B. Summersgill, R.A. Huddart, D.C. Gilbert and J.M. Shipley. “IGF1R signaling in testicular germ cell tumor cells impacts on cell survival and acquired cisplatin resistance”. J Pathol. 2018; 244 (2) :242-253.

D. Castel, C. Philipe, R. Calmon, L. Le Dret, N. Truffaux, N. Boddaert, M. Pages, K.R. Taylor, P. Saulnier, L. Lacroix, A. Mackay, C. Jones, C. Sainte-Rose, T. Blauwblomme, F. Andreiuolo, S. Puget, J. Grill, P. Varlet, M-A. Debily. “The type of histone H3 variant with Lys27Met (K27M) mutation is a prognostic marker associated with two different phenotypes of diffuse intrinsic pontine gliomas”. Acta Neuropathol, 2015; 130 (6) :815-27.

J. Renshaw, K.R. Taylor, R. Bishop, M. Valenti, A.D.H. Brandon, S. Gowan, S.A. Eccles, R.R. Ruddle, L.D. Johnson, F. Raynaud, J.L. Selfe, K. Thyway, T. Pietsch, A.D. Pearson, and J. Shipley. “Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.” Clinical Cancer Research. 2013; 19 (21) :5940- 51. *Comment in Clin Can Res (Jahangiri and Weiss, 2013).

L. Bjerke, A. Mackay, M. Nandhabalan, A. Burford, A. Jury, S. Popov, D.A. Bax, D. Carvalho, K.R. Taylor, M. Vinci, I. Bajrami, I.M. McGonnell, C.J. Lord, R.M. Reis, D. Hargrave, A. Ashworth and C. Jones. “Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN”. Cancer Discovery. 2013; 3(5):512-519.

R. Tonelli, A McIntyre, C. Camerin, Z.S. Walters, K. Di Leo, J. Selfe, S. Purgato, Missiaglia, A. Tortori, J. Renshaw, A. Astolfi, K.R. Taylor, S. Serravalle, R. Bishop, C. Nannk, L.J. Valentijn, A. Faccini, I. Leuschner, S. Formica, J.S. Res- Filho, V. Ambrosini, K. Thyway, M. Franzoni, B. Summersgill, R. Marchelli, P. Hrelia, G. Cantelli-Forti, S. Fanti, R. Corradini, A. Pession, et Int [including K.R. Taylor], J. Shipley. “Antitumour activity of sustained N/myc reduction in rhadomyosarcomas and transcriptional block by antigene therapy”. Clinical Cancer Research. 2012; 18(3):796-807.